This study reports important negative results by showing that genetic removal of the RNA-binding protein PTBP1 in astrocytes is not sufficient to induce their conversion into neurons, challenging ...

Australian researchers have discovered a promising new strategy to suppress the growth of aggressive and hard-to-treat ...

N6-methyladenosine (m6A) serves as a critical RNA modification, dynamically governing RNA metabolism through its influence on RNA stability, splicing, ...

Catch up with the most important stories from around Europe and beyond - latest news, breaking news, World, Business, ...

Meet 12 biotech companies with promising genetic disease therapies that successfully closed funding rounds recently.

Abivax shares surged 500% after positive phase 3 results for obefazimod in moderate-to-severe ulcerative colitis. Click here ...

Abivax dazzled investors and analysts with positive data from a pair of Phase III induction trials assessing obefazimod in adults with moderately to severely active ulcerative colitis. The results ...